Active ADP-ribosylation factor-1 (ARF1) is required for mitotic golgi fragmentation

被引:33
|
作者
Xiang, Yi
Seemann, Joachim
Bisel, Blaine
Punthambaker, Sukanya
Wang, Yanzhuang
机构
[1] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA
[2] Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA
关键词
D O I
10.1074/jbc.M611716200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In mammalian cells the Golgi apparatus undergoes an extensive disassembly process at the onset of mitosis that is believed to facilitate equal partitioning of this organelle into the two daughter cells. However, the underlying mechanisms for this fragmentation process are so far unclear. Here we have investigated the role of the ADP-ribosylation factor-1 (ARF1) in this process to determine whether Golgi fragmentation in mitosis is mediated by vesicle budding. ARF1 is a small GTPase that is required for COPI vesicle formation from the Golgi membranes. Treatment of Golgi membranes with mitotic cytosol or with purified coatomer together with wild type ARF1 or its constitutive active form, but not the inactive mutant, converted the Golgi membranes into COPI vesicles. ARF1-depleted mitotic cytosol failed to fragment Golgi membranes. ARF1 is associated with Golgi vesicles generated in vitro and with vesicles in mitotic cells. In addition, microinjection of constitutive active ARF1 did not affect mitotic Golgi fragmentation or cell progression through mitosis. Our results show that ARF1 is active during mitosis and that this activity is required for mitotic Golgi fragmentation.
引用
收藏
页码:21829 / 21837
页数:9
相关论文
共 50 条
  • [1] Genetic analysis of ADP-Ribosylation Factor 1 (ARF1) in yeast
    Click, ES
    Stearns, T
    Botstein, D
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 210A - 210A
  • [2] Multiple and stepwise interactions between coatomer and ADP-ribosylation factor-1 (Arf1)-GTP
    Sun, Zhe
    Anderl, Frank
    Froehlich, Kathrin
    Zhao, Liyun
    Hanke, Stefan
    Bruegger, Britta
    Wieland, Felix
    Bethune, Julien
    TRAFFIC, 2007, 8 (05) : 582 - 593
  • [3] The ADP-ribosylation factor 1 (Arf1) is involved in regulating copper uptake
    Southon, Adam
    Greenough, Mark
    Hung, Ya Hui
    Norgate, Melanie
    Burke, Richard
    Camakaris, James
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2011, 43 (01): : 146 - 153
  • [4] Structural elements of ADP-ribosylation factor 1 (ARF1) required for functional interaction with cytohesin-1.
    Rodriguez, P
    Patton, WA
    Adamik, R
    Yoo, HS
    Zang, GF
    Moss, J
    Vaughan, M
    FASEB JOURNAL, 1999, 13 (07): : A1366 - A1366
  • [5] Identification of a new inhibitor of the Golgi system, targeting ADP-ribosylation Factor 1 (Arf1) with potential for cancer therapy
    Ohashi, Yoshimi
    Iijima, Hiroshi
    Yamaotsu, Noriyuki
    Yamazaki, Kanami
    Sato, Shigeo
    Okamura, Mutsumi
    Sugimoto, Kenji
    Dan, Shingo
    Hirono, Shuichi
    Yamori, Takao
    CANCER RESEARCH, 2012, 72
  • [6] Role of ADP-ribosylation factor1 (ARF1) in vesicular trafficking in plants
    Memon, A. R.
    Usluer, S.
    FEBS JOURNAL, 2006, 273 : 60 - 60
  • [7] AMF-26, a Novel Inhibitor of the Golgi System, Targeting ADP-ribosylation Factor 1 (Arf1) with Potential for Cancer Therapy
    Ohashi, Yoshimi
    Iijima, Hiroshi
    Yamaotsu, Noriyuki
    Yamazaki, Kanami
    Sato, Shigeo
    Okamura, Mutsumi
    Sugimoto, Kenji
    Dan, Shingo
    Hirono, Shuichi
    Yamori, Takao
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (06) : 3885 - 3897
  • [8] Overexpression of ADP-Ribosylation Factor 1 (ARF1) in Human Gastric Cancer and Its Clinicopathological Significance
    Wang, Chia-Siu
    Lin, Kwang-Huei
    GASTROENTEROLOGY, 2012, 142 (05) : S1068 - S1069
  • [9] Development of a Novel Inhibitor of ADP-Ribosylation Factor 1 (Arf1) That Has Potential for Cancer Therapy
    Ohashi, Y.
    Iijima, H.
    Yamaotsu, N.
    Yamazaki, K.
    Okamura, M.
    Sugimoto, K.
    Hirono, S.
    Dan, S.
    Yamori, T.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 158 - 158
  • [10] The assembly of VLDL is dependent on ADP-ribosylation factor 1 (ARF1) end phospholipase D (PLD)
    Asp, L
    Claesson, C
    Olofsson, SO
    MOLECULAR BIOLOGY OF THE CELL, 1999, 10 : 414A - 414A